866-997-4948(US-Canada Toll Free)

Topical Drug Delivery Partnering 2010-2015

Published By :

Current Partnering

Published Date : Mar 2015

Category :

Drug Delivery

No. of Pages : 150 Pages

Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.

  • Trends in topical drug delivery partnering deals
  • Top topical drug delivery deals by value
  • Deals listed by company A-Z, deal type, stage of development, therapy type

Topical Drug Delivery Partnering 2010-2015 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter topical drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 150 links to online copies of actual topical drug delivery deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. 

The initial chapters of this report provide an orientation of topical drug delivery dealmaking and business activities. 

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in topical drug delivery dealmaking since 2010

Chapter 3 is the most popular chapter that includes details of average headline, upfront, milestone and royalty terms. 

Chapter 4 provides a review of the leading topical drug delivery deals since 2010. Deals are listed by headline value, most active of all biopharma companies and signed by big pharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides a comprehensive directory of topical drug delivery partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and therapy type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in topical drug delivery partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about topical drug delivery partnering in the research, development and commercialization of drug delivery technologies and products.

Report scope

Topical Drug Delivery Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to topical drug delivery trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

  • Trends in topical drug delivery dealmaking in the biopharma industry since 2010
  • Access to summary headline, upfront, milestone and royalty data
  • Access to over 150 topical drug delivery actual deal records
  • The leading topical deals by value since 2010

In Topical Drug Delivery Partnering 2010-2015, the available deals are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Company A-Z
  • Industry sector
  • Stage of development at signing
  • Deal component type
  • Therapy type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in topical drug delivery dealmaking
2.1. Introduction
2.2. Topical drug delivery partnering over the years
2.3. Big pharma topical drug delivery dealmaking activity
2.4. Topical drug delivery partnering by industry type
2.5. Topical drug delivery partnering by deal type
2.6. Topical drug delivery partnering by disease type

Chapter 3 –Average financial deal terms for topical drug delivery partnering
3.1 Topical drug delivery deals by headline values
3.2 Topical drug delivery upfront payments
3.3 Topical drug delivery milestone payments
3.4 Topical drug delivery royalty rates

Chapter 4 – Leading topical drug delivery deals
4.1. Introduction
4.2. Most active in topical drug delivery partnering
4.3. Top topical drug delivery deals by value

Chapter 5 – Topical drug delivery partnering dealmaking directory
5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By stage of development
5.5. By industry sector
5.6. By therapy area
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Order Form – Upgrades to subscription access products

List of Chart


Figure 1: Topical drug delivery partnering since 2010
Figure 2: Big pharma – top 50 – Topical drug delivery deals 2010 to 2015
Figure 3: Big pharma topical drug delivery deal frequency – 2010 to 2015
Figure 4: Topical drug delivery partnering by industry sector since 2010
Figure 5: Topical drug delivery partnering by deal type since 2010
Figure 6: Topical drug delivery partnering by disease type since 2010
Figure 7: Topical drug delivery deals with a headline value
Figure 8: Topical drug delivery deals with an upfront value
Figure 9: Topical drug delivery deals with a milestone value
Figure 10: Topical drug delivery deals with a royalty rate value
Figure 11: Active topical drug delivery dealmaking activity– 2010 to 2015
Figure 12: Top topical drug delivery deals by value since 2010

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *